AnaptysBio

3 followers
‌

AnaptysBio is a clinical-stage antibody development company advancing therapeutic antibody product candidates focused on unmet medical needs in inflammation.

Industries

Employees

51-200

Links


Org chart

Hamza Suri
President & CEO
Collapse
Oscar Velastegui
Executive Director, Program Management
Kenneth Luu
Vice President, Clinical Pharmacology & Toxicology
Ben Stone
Acting Chief Business Officer
Martin Dahl
SVP, Research
Cynthia Alexander
Director, Medical Affairs
Nick Montemarano
Senior Director, Investor Relations and Strategic Communications
Mark R. Rigby
Executive Director, Clinical Development, AnaptysBio
Bryan Linggi
Senior Director, Translational Research
Anne Severtson
Sr. Director Clinical Operations
David V.
Director Of Clinical Operations
May H.
Sr. Director Of Clinical Operations
Cory Okuna
Executive Director, Head of Information Technology
Eric Loumeau
Chief Legal Officer
Doug Rich
SVP, CMC

Board & advisors

Luisa Salter-Cid
Scientific Advisor
Christopher Hunter
Scientific Advisor
Rita Jain
Director
John Schmid
Director
Dolca Thomas
Scientific Advisor
John Orwin
Board Chairman
Daniel Faga
Director